These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26571714)

  • 1. [The Cutting-edge of Medicine; Pre-clinical diagnosis of neurodegenerative diseases].
    Oizumi H; Takeda A
    Nihon Naika Gakkai Zasshi; 2015 Feb; 104(2):323-9. PubMed ID: 26571714
    [No Abstract]   [Full Text] [Related]  

  • 2. Looking backward to move forward: early detection of neurodegenerative disorders.
    DeKosky ST; Marek K
    Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition in REM sleep behavior disorder - A window into preclinical dementia?
    Postuma RB; Gagnon JF; Montplaisir J
    Sleep Med; 2008 May; 9(4):341-2. PubMed ID: 17869575
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurodegenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention.
    Trojanowski JQ; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):491-5. PubMed ID: 21821094
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional imaging in neurodegenerative disorders: past, present and future.
    Pagani M; Sonni I; Capriotti G
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):329-31. PubMed ID: 25519924
    [No Abstract]   [Full Text] [Related]  

  • 6. [The cutting-edge of medicine; development of diagnostic biomarkers for neurodegenerative diseases].
    Kasai T; Tokuda T
    Nihon Naika Gakkai Zasshi; 2012 Nov; 101(11):3247-55. PubMed ID: 23342600
    [No Abstract]   [Full Text] [Related]  

  • 7. Bibliography. Current world literature. Degenerative and cognitive diseases.
    Curr Opin Neurol; 2006 Dec; 19(6):633-41. PubMed ID: 17201041
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurodegenerative disorders. American College of Radiology. ACR Appropriateness Criteria.
    Braffman B; Drayer BP; Anderson RE; Davis PC; Deck MD; Hasso AN; Johnson BA; Masaryk T; Pomeranz SJ; Seidenwurm D; Tanenbaum L; Masdeu JC
    Radiology; 2000 Jun; 215 Suppl():597-605. PubMed ID: 11037470
    [No Abstract]   [Full Text] [Related]  

  • 9. The Dutch Parelsnoer Institute--Neurodegenerative diseases; methods, design and baseline results.
    Aalten P; Ramakers IH; Biessels GJ; de Deyn PP; Koek HL; OldeRikkert MG; Oleksik AM; Richard E; Smits LL; van Swieten JC; Teune LK; van der Lugt A; Barkhof F; Teunissen CE; Rozendaal N; Verhey FR; van der Flier WM
    BMC Neurol; 2014 Dec; 14():254. PubMed ID: 25551191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCI is not a clinically useful concept.
    Visser PJ; Brodaty H
    Int Psychogeriatr; 2006 Sep; 18(3):402-9; discussion 409-14. PubMed ID: 17001760
    [No Abstract]   [Full Text] [Related]  

  • 11. Early diagnosis of neurodegenerative diseases - the long awaited Holy Grail and bottleneck of modern brain research - 19th HUPO BPP workshop: May 22-24, 2013, Dortmund, Germany.
    Schrötter A; Magraoui FE; Gröttrup B; Wiltfang J; Heinsen H; Marcus K; Meyer HE; Grinberg LT; Park YM
    Proteomics; 2013 Oct; 13(20):2938-41. PubMed ID: 24108682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic imaging of neurodegenerative diseases].
    Iwata M
    Nihon Naika Gakkai Zasshi; 2006 Oct; 95(10):2099-104. PubMed ID: 17100272
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia].
    Uspenskaia OV; Iakhno NN; Belushkina NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):36-40. PubMed ID: 20823828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural neuroimaging in geriatric psychiatry.
    Smith GS; Eyler LT
    Am J Geriatr Psychiatry; 2006 Oct; 14(10):809-11. PubMed ID: 17001020
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment.
    Espay AJ; Paviour DC; O'Sullivan JD; Schmidt RE; Revilla FJ; Metman LV
    Mov Disord; 2010 Sep; 25(12):1860-7. PubMed ID: 20669183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A frontline defense against neurodegenerative diseases:the development of early disease detection methods.
    Baldacci F; Lista S; Vergallo A; Palermo G; Giorgi FS; Hampel H
    Expert Rev Mol Diagn; 2019 Jul; 19(7):559-563. PubMed ID: 31159600
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological and cognitive decline in adolescence.
    Forsyth RJ
    J Neurol Neurosurg Psychiatry; 2003 Mar; 74 Suppl 1(Suppl 1):i9-16. PubMed ID: 12611929
    [No Abstract]   [Full Text] [Related]  

  • 18. The early biomarker challenge in neurodegenerative disorders.
    Turner MR
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1190-1191. PubMed ID: 31243045
    [No Abstract]   [Full Text] [Related]  

  • 19. Life sciences: Biomarkers on the brain.
    Katsnelson A
    Nature; 2011 Nov; 479(7371):139-40. PubMed ID: 22103003
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of personality characteristics on the clinical expression in neurodegenerative disorders--a review.
    von Gunten A; Pocnet C; Rossier J
    Brain Res Bull; 2009 Oct; 80(4-5):179-91. PubMed ID: 19616079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.